Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedFeb 12, 2014Pyridostigmine Bromide Tablets USPFailed Dissolution Specification: Corepharma Inc. is recalling Pyridostigmine Bromide Tablets USP 60 mg due to an out of specification dissolution test generated at the...Corepharma LLC · D-1079-2014Class IITerminatedFeb 12, 2014Dollar General Triple Antibiotic OintmentMicrobial Contamination of Non-Sterile Products: Elevated counts of gram positive rods were found during environmental testingFaria Limited LLC dba Sheffield Pharmaceuticals · D-1078-2014Class IITerminatedFeb 12, 2014FAMILY wellness Triple Antibiotic Ointment. NET WT 1 OZMicrobial Contamination of Non-Sterile Products: Elevated counts of gram positive rods were found during environmental testingFaria Limited LLC dba Sheffield Pharmaceuticals · D-1077-2014Class IITerminatedFeb 12, 2014Dr. Sheffield Triple Antibiotic OintmentMicrobial Contamination of Non-Sterile Products: Elevated counts of gram positive rods were found during environmental testingFaria Limited LLC dba Sheffield Pharmaceuticals · D-1076-2014Class IITerminatedFeb 12, 2014Hydralazine HCL TabletsFailed Impurities/Degradation Specifications:There is a potential for the tablets to be out of specification for impurities throughout shelf life.Teva Pharmaceuticals USA · D-1075-2014Class IITerminatedFeb 12, 2014Hydralazine HCL TabletsFailed Impurities/Degradation Specifications:There is a potential for the tablets to be out of specification for impurities throughout shelf life.Teva Pharmaceuticals USA · D-1074-2014Class IIITerminatedFeb 12, 2014Timolol Maleate Sterile Ophthalmic SolutionDefective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the...PACK Pharmaceuticals, LLC · D-1073-2014Class IIITerminatedFeb 12, 2014Timolol Maleate Sterile Ophthalmic SolutionDefective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the...PACK Pharmaceuticals, LLC · D-1072-2014Class IIITerminatedFeb 12, 2014Timolol Maleate Sterile Ophthalmic SolutionDefective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the...PACK Pharmaceuticals, LLC · D-1071-2014Class IIITerminatedFeb 12, 2014Timolol Maleate Sterile Ophthalmic SolutionDefective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the...PACK Pharmaceuticals, LLC · D-1070-2014Class IIITerminatedFeb 12, 2014Ofloxacin Ophthalmic SolutionDefective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the...PACK Pharmaceuticals, LLC · D-1069-2014Class IIITerminatedFeb 12, 2014Ofloxacin Ophthalmic SolutionDefective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the...PACK Pharmaceuticals, LLC · D-1068-2014Class IITerminatedFeb 12, 2014HEALTH & BEYOND DR. LARRY'S Tranquility DIETARY SUPPLEMENT 30 CapsulesMarketed Without an Approved NDA/ANDA; product found to contain Doxepin (an antidepressant) and Chlorpromazine (an antipsychotic)Health & Beyond · D-1067-2014Class IITerminatedFeb 12, 2014The firm is recalling all lots of sterile products compounded by the pharmacy that are within expiryLack of Assurance of Sterility: The recall is being initiated due to the lack of sterility assurance and concerns associated with the quality control processes...Apothecure, Inc · D-1066-2014Class IIITerminatedFeb 12, 2014Namenda XRFailed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.Forest Pharmaceuticals Inc · D-1065-2014Class IIITerminatedFeb 12, 2014Namenda XRFailed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.Forest Pharmaceuticals Inc · D-1064-2014Class IIITerminatedFeb 12, 2014Namenda XRFailed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.Forest Pharmaceuticals Inc · D-1063-2014Class IITerminatedFeb 12, 2014CHILDREN'S IBUPROFENCGMP Deviation: Discoloration; Product fails specification for appearance/color. A complaint was received regarding an abnormal appearance of children's ibuprofen...Central Shared Services dba Parallon · D-1062-2014Class IITerminatedFeb 12, 2014Valacyclovir Hydrochloride TabletsPresence of Foreign Tablets/Capsules: Potential of Pravastatin tablet fragments in bottles of Valacyclovir 1 gm Tablets.Teva Pharmaceuticals USA, Inc. · D-1061-2014Class IITerminatedFeb 12, 2014Diclofenac Sodium and Misoprostol Delayed-Release TabletsFailed Tablet/Capsule Specifications: Broken tabletsActavis Inc · D-1060-2014Class IIITerminatedFeb 12, 2014Glipizide XLFailed Dissolution Specification; the bulk lot yielded an out of specification result at the 8 hr timepoint, 18 month intervalGreenstone Llc · D-1059-2014Class IIITerminatedFeb 12, 2014Glucotrol XLFailed Dissolution Specification; 8 hr stability timepointPfizer Inc. · D-1058-2014Class ITerminatedFeb 12, 201450 mg Nitroglycerin in 5% Dextrose InjectionPresence of Particulate Matter; particulate matter in one vial identified as silicone rubber and EPDM rubber from the vial stopper.Baxter Healthcare Corp. · D-1057-2014Class IITerminatedFeb 12, 2014Cornea CoatMarketed without an Approved NDA/ANDA.Insight Instruments, Inc. · D-1056-2014Class IITerminatedFeb 12, 2014Dicopanol FusePaq Kit for Oral SuspensionMicrobial Contamination of Non-Sterile Products: Fusion Pharmaceuticals is recalling the Dicopanol FusePaq Kit due to Total Yeasts and Molds Count above USP limits.Fusion Pharmaceuticals, LLC · D-1055-2014Class ITerminatedFeb 12, 2014Cefepime for Injection USP and Dextrose Injection USPPresence of Particulate Matter: The 1g Cefepime for Injection USP and Dextrose Injection USP lot has been found to contain visible organic particulate matter in a...B. Braun Medical Inc · D-1054-2014Class IITerminatedFeb 5, 2014Hydrocodone Bitartrate and Acetaminophen Tablets USPFailed Tablet/Capsule Specifications; Product contains broken tablets.Watson Laboratories Inc · D-1053-2014Class ITerminatedFeb 5, 2014Sermorelin/GHRP-6Lack of Assurance of Sterility: The recall is being initiated due to a lack of sterility assurance and concerns associated with the quality control processes identified...NuVision Pharmacy, Inc. · D-1052-2014Class ITerminatedFeb 5, 2014HCG (Lyophilized) Stock # 21714Lack of Assurance of Sterility: The recall is being initiated due to a lack of sterility assurance and concerns associated with the quality control processes identified...NuVision Pharmacy, Inc. · D-1051-2014Class ITerminatedFeb 5, 2014Hydravax High Potency Diuretic Weight Loss SolutionMarketed Without an Approved NDA/ANDA; this product is being recalled for containing an undeclared diuretic called Triamterene, an FDA approved prescription only...IQ Formulations, LLC · D-1050-2014Class ITerminatedFeb 5, 2014SolirisPresence of Particulate Matter: Failed the appearance test for the presence of visible particles.Alexion Pharmaceuticals, Inc. · D-1049-2014Class IITerminatedFeb 5, 2014Mercuroclear Antiseptic Anesthetic First Aid Helps prevent infection and relieves pain and itching of minor...Microbial Contamination of Non-Sterile Product(s): The product was found to be contaminated with Bulkholderia sp.Humco Holding Group, Inc · D-1048-2014Class ITerminatedFeb 5, 2014eXtenZone capsulesMarketed Without An Approved NDA/ANDA: FDA analysis found eXtenZone which is marketed as a dietary supplement to contain undeclared desmethyl carbondenafil and...SS Wholesale Inc. dba Jobbers Wholesale · D-1047-2014Class ITerminatedFeb 5, 2014MaXtremeZEN capsulesMarketed Without An Approved NDA/ANDA: FDA analysis found MaXtremeZEN which is marketed as a dietary supplement to contain undeclared desmethyl carbondenafil and...SS Wholesale Inc. dba Jobbers Wholesale · D-1046-2014Class ITerminatedFeb 5, 2014Rhino 5 capsulesMarketed Without An Approved NDA/ANDA: FDA analysis found Rhino 5 which is marketed as a dietary supplement to contain undeclared desmethyl carbondenafil and dapoxetine...SS Wholesale Inc. dba Jobbers Wholesale · D-1045-2014Class IIITerminatedFeb 5, 2014KETOCONAZOLE CREAMFailed Impurities/Degradation Specifications: Out-of-Specification degradant results.Fougera Pharmaceuticals Inc. · D-1044-2014Class IIITerminatedFeb 5, 2014BuPROPion Hydrochloride Extended-Release TabletFailed Dissolution Specifications: Failed stability testing for dissolution test at 18 months.Actavis Inc · D-1043-2014Class IITerminatedFeb 5, 2014Pantaprazole Sodium Delayed Release TabletsFailed Dissolution Specifications; 12 month acid dissolution test results were above upper limit specifications.Wockhardt Usa Inc. · D-1042-2014Class IITerminatedFeb 5, 2014ROHTO Redness ReliefLack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Rohto Hydra, Rohto Relief and Rohto Cool eye drops, due to concerns related...The Mentholatum Co. · D-1041-2014Class IITerminatedFeb 5, 2014ROHTO Cooling Eye DropsLack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Rohto Hydra, Rohto Relief and Rohto Cool eye drops, due to concerns related...The Mentholatum Co. · D-1040-2014